Institutional ownership · Form 13F
KYTX institutional ownership
Kyverna Therapeutics, Inc. - Common Stock: reported institutional holdings as of 2026-06-30 (filed through 2026-08-31), aggregated by StockEyes from SEC Form 13F information tables. KYTX is one of 2732 tickers in the validated publication set. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.
KYTX: change since the prior quarter's filings
More managers reported a position, with the count rising from 111 in the quarter ended 2026-03-31 to 120 in the quarter ended 2026-06-30 (+9, 8.1%). Total reported shares rose to 37,594,332 (+2,770,799, 8.0%), moving the same way as the manager count. Among the 22 managers listed as top holders in both quarters, the largest increases were BlackRock, Inc. (+2,257,729 shares) and AIGH Capital Management LLC (+795,797 shares), among 9 managers who added shares, and the largest decreases were MILLENNIUM MANAGEMENT LLC (-365,728 shares) and D. E. Shaw & Co., Inc. (-252,235 shares), among 6 managers who reduced shares. STATE STREET CORP (982,233 shares), WELLS FARGO & COMPANY/MN (373,009 shares) and 6 more entered the listed top holders; Balyasny Asset Management L.P. (1,125,321 shares in the prior quarter), MARSHALL WACE, LLP (605,512 shares in the prior quarter) and 6 more dropped out of the listed top holders.
New to 13F data? Read how to read a 13F filing, or see where institutions moved overall in the Smart Money Report.
Reported totals, quarter ended 2026-06-30
120 reporting managers held 37,594,332 shares, reported value $323,609,676 exactly as filed. Values are position values transcribed from the filings, not current market prices.
Reported quarter-over-quarter change (quarter ended 2026-03-31 to quarter ended 2026-06-30): reporting managers +9, reported shares +2,770,799 (+7.96%), reported value +12.77%. These changes compare two filing snapshots.
Shares outstanding check: 60,896,872 shares reported by the issuer (SEC XBRL, period ended 2026-06-30). Reported 13F shares equal 61.7% of that figure. This page passed the publication sanity gate before listing.
KYTX in this quarter's filings
Concentration check: the largest reported position, GordonMD Global Investments LP with 4,244,818 shares, is 11.3% of all shares reported for KYTX this quarter. The five largest reporting managers together account for 45.7% of the reported total, so the headline total is spread across a broad manager base rather than a few holders.
Reported quarter-over-quarter change: the reporting-manager count rose by 9 versus the quarter ended 2026-03-31, and reported shares moved +7.96% (+2,770,799 shares). That is a comparison of two filing snapshots, not a record of trades on any single day.
Shares-outstanding cross-check: reported 13F shares equal 61.7% of the issuer share count used at the publication gate (60,896,872 shares, issuer period ended 2026-06-30). The gate publishes a ticker only when that relationship is plausible; lending chains can push reported totals above a simple ownership share, which is why the figure is a sanity check and not an ownership percentage.
Largest reporting managers, KYTX
| # | Manager | Shares | Value as filed | Share of reported total |
|---|---|---|---|---|
| 1 | GordonMD Global Investments LP | 4,244,818 | $37,821,328 | 11.3% |
| 2 | GILEAD SCIENCES, INC. | 4,126,119 | $36,763,720 | 11.0% |
| 3 | BlackRock, Inc. | 3,134,807 | $27,931,130 | 8.3% |
| 4 | Bain Capital Life Sciences Investors, LLC | 2,885,000 | $25,705,350 | 7.7% |
| 5 | AIGH Capital Management LLC | 2,795,797 | $24,910,552 | 7.4% |
| 6 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2,000,000 | $17,820,000 | 5.3% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1,897,451 | $16,906,288 | 5.0% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1,049,430 | $9,352,537 | 2.8% |
| 9 | Insight Holdings Group, LLC | 989,054 | $8,812,471 | 2.6% |
| 10 | MORGAN STANLEY | 982,307 | $8,752,355 | 2.6% |
| 11 | STATE STREET CORP | 982,233 | $8,751,696 | 2.6% |
| 12 | Propel Bio Management, LLC | 883,198 | $7,869,294 | 2.3% |
| 13 | Woodline Partners LP | 845,325 | $7,531,846 | 2.2% |
| 14 | MILLENNIUM MANAGEMENT LLC | 639,780 | $5,700,440 | 1.7% |
| 15 | MBB PUBLIC MARKETS I LLC | 614,477 | $5,474,990 | 1.6% |
Manager names and figures are transcribed from each manager's own Form 13F information table. A manager listing shares in this snapshot does not mean it holds them today.
Reported change, 2026-03-31 to 2026-06-30
| Quarter ended | Filed through | Reporting managers | Reported shares | Value as filed |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-29 | 111 | 34,823,533 | $286,976,926 |
| 2026-06-30 | 2026-08-31 | 120 | 37,594,332 | $323,609,676 |
Every change figure on this page is a reported quarter-over-quarter change between filing snapshots. It is not real-time trading activity.
KYTX reported totals over time
Quarter ended 2026-06-30: 120 reporting managers · 37,594,332 reported shares · $323,609,676 value as filed.
The full archived series is part of StockEyes Pro. Continue with Google to sign in.
Quarter-end 13F filed data, long positions only; filings arrive up to 45 days after quarter end.
CUSIPs behind the KYTX total
The validated bridge mapped 1 current CUSIP(s) to KYTX for this quarter: 501976104. Option pseudo-CUSIPs, units, warrants, and preferred classes are excluded from these common-share totals. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.
What this page is and is not
Form 13F reports are quarterly holdings snapshots. Managers file up to about 45 days after quarter-end, so these figures describe reported positions as of the quarter-end date, not holdings today. 13F lists reportable long positions from managers above the SEC reporting threshold and omits short positions entirely.
This page is informational only. It is not investment advice, a recommendation, or a signal to buy or sell. Source: SEC Form 13F bulk data set for filings through 2026-08-31 (period ended 2026-06-30), joined to tickers through StockEyes' validated CUSIP bridge. Methodology and coverage are documented on the institutional ownership hub.
Insider transactions for KYTX (officer and director buys and sells) are covered by InsiderTrace: insidertrace.com/stock/kytx. StockEyes does not duplicate insider transaction tables.
Related StockEyes pages
Latest headlines tagged KYTX are on the market news wire. Upcoming earnings and market dates are on the events calendar. The term itself is defined in the institutional investor glossary entry, and the research workflow behind pages like this one is walked through in how to research a stock and how to compare SEC filings.